<DOC>
	<DOCNO>NCT01142193</DOCNO>
	<brief_summary>The purpose study examine safety effectiveness USL255 adjunctive therapy patient refractory partial onset-seizures .</brief_summary>
	<brief_title>Study Evaluate Safety Effectiveness USL255 Patients With Refractory Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Subject confirm diagnosis partialonset seizure without secondary generalization least 12 month prior Visit 1 . Currently stable dose regimen 1 3 AEDs least 4weeks prior Visit 1 ( 12 week phenobarbital primidone ) . Have minimum 8 partialonset seizure 21 consecutive seizure free day , 8week baseline . Have history seizure episodes last less 30 minute several seizure occur frequency initiation completion individual seizure distinguish , within 3 month prior Visit 1 . Have history pseudoseizures , status epilepticus , within 3 month prior Visit 1 . Have history metabolic acidosis , nephrolithiasis , ureterolithiasis , narrow angle glaucoma . Have history suicidal attempt , suicidal ideation , uncontrolled psychiatric illness within 2 year Visit 1 . Currently take , take felbamate within past 18 month , take vigabatrin past . Have take topiramate within past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>partial onset seizure</keyword>
	<keyword>adjunctive therapy</keyword>
</DOC>